| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.03 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |